-transparent.png){kind=logo}
Cultured amniotic fluid cells from two mucolipidosis type IV (MLIV)-affected fetuses demonstrated accumulation of phospholipids and gangliosides when compared with normal controls. Like cultured skin fibroblasts from MLIV patients, cultured amniotic cells from the affected fetuses accumulated primarily lyso phospholipids and this could be demonstrated by radioactive labelling with appropriate precursors, either inorganic phosphate or oleic acid. Furthermore, like cultured skin fibroblasts, there was significant retention of exogenously supplied GD1A ganglioside in the affected amniotic cells. This storage was previously demonstrated to be unique to MLIV and thus can be used at present as a specific procedure for prenatal diagnosis of MLIV.
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
January 1988,
Journal of inherited metabolic disease,
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
January 1988,
Enzyme,
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
September 1980,
Clinica chimica acta; international journal of clinical chemistry,
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
June 1986,
Clinica chimica acta; international journal of clinical chemistry,
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
August 1987,
American journal of medical genetics,
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
April 1990,
Prenatal diagnosis,
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
October 1982,
Prenatal diagnosis,
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
January 1976,
Experimental cell biology,
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
January 1977,
The Journal of pediatrics,
M Zeigler, and
R Bargal, and
V Suri, and
B Meidan, and
G Bach
January 1975,
Birth defects original article series,
